Date: November 14, 2026
Regulatory Compliance Disclosure
Amanta Healthcare Limited has formally responded to a surveillance query from the National Stock Exchange of India Limited (NSE) regarding unusual trading activity in its securities.
The query, referenced under NSE email dated November 12, 2026 with reference number NSE/CM/Surveillance/17785, specifically addressed a "significant increase in the volume of security across Exchanges, in the recent past."
Company's Position on Volume Increase
The company stated that it has "no undisclosed information, announcement, or event, including any impending corporate action" that might explain the unusual trading volume or price behavior of its securities.
This assessment is based on the company's opinion regarding information that would require disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Corporate Details
Registered & Corporate Office: 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA
Corporate Identification Number: L24139GJ1994PLC023944